Farther Finance Advisors »

Zentalis Pharmaceuticals shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $151 55 2.76
2024-09-30 $37 10 3.70
2024-06-30 $42 10 4.20
2024-03-31 $161 10 16.10
2023-12-31 $152 10 15.20

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Vanguard Morningstar Value Etf Etf (VTV)
Microsoft Corp Stock (MSFT)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Qqq Trust Series I Etf (QQQ)

View all positions for Farther Finance Advisors

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals